Literature DB >> 21115331

Anti-inflammatory, anticholinesterase and antioxidative constituents from the roots and the leaves of Salvia nipponica Miq. var. formosana.

Hsiu-Hui Chan1, Tsong-Long Hwang, Chung-Ren Su, Mopur Vijaya Bhaskar Reddy, Tian-Shung Wu.   

Abstract

Reactive oxygen species and granule proteases produced by neutrophils contribute to the pathogenesis of inflammatory diseases. The extracts of the roots and the leaves of Salvia nipponica var. formosana were showed potent inhibitory effects on superoxide anion production in fMLP/CB-activated human neutrophils as well as other anti-inflammatory effects, and led to the isolation of 25 compounds. Among them, compounds 8, 12, 13, 14, 15, 17 and 20 were exhibited more potent inhibitory effect on superoxide anion generation and elastase release by human neutrophils in response to fMLP/CB. Moreover, those isolated compounds also showed significant anticholinesterase and antioxidative activities. To the best of our knowledge, this is the first report of phytochemical and biological activity study on S. nipponica var. formosana. 2010. Published by Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115331     DOI: 10.1016/j.phymed.2010.06.017

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  3 in total

1.  Apoptotic and anti-angiogenic effects of Salvia triloba extract in prostate cancer cell lines.

Authors:  Harika Atmaca; Emir Bozkurt
Journal:  Tumour Biol       Date:  2015-10-12

2.  HPTLC Fingerprinting and Cholinesterase Inhibitory and Metal-Chelating Capacity of Various Citrus Cultivars and
Olea europaea.

Authors:  Fatma Sezer Senol; Anita Ankli; Eike Reich; Ilkay Erdogan Orhan
Journal:  Food Technol Biotechnol       Date:  2016-09       Impact factor: 3.918

Review 3.  Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine.

Authors:  Cheng Zhang; Ning Wang; Hor-Yue Tan; Wei Guo; Sha Li; Yibin Feng
Journal:  Integr Cancer Ther       Date:  2018-05-28       Impact factor: 3.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.